SIMCERE PHARMA (02096.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec7

Xiansheng Pharma's Ensuzhu® Included in National Medical Insurance Directory, Endu® Renewal Completed

23:12

Dec3

Wangsan Wangshui Grants Xiansheng Pharmaceutical Exclusive License for New Indications of VV116

08:35

Vigonvita Life Science Grants Xian-Janssen Exclusivity on VV116 for New Indications

08:30

Dec1

Xian Shen Pharmaceutical Grants 15.4081 Million RSUs to 97 Eligible Participants

12:18

Nov14

Xiansheng Pharmaceutical Initiates Phase II Clinical Trial for SIM0278

06:24

Nov10

Simcere Launches Phase II Clinical Trial of SIM0278

09:48

Schedules & Filings

Schedules

Filings

Aug21

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 1.962 B, Net Income 330.33 M, EPS 0.1351

Jul14

Distribution Plan(CST)

Cash dividend 0.1748 HKD

Jun19

Distribution Plan(CST)

Cash dividend 0.1748 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More